National Policy for Access to Plasma Derived Medicinal Products from Human Plasma for Clinical / Therapeutic Use
This page covers about National Policy for Access to Plasma Derived Medicinal Products from Human Plasma for Clinical / Therapeutic Use, addendum to NBP